# Tonix Pharmaceuticals, Inc. — Form D

Tonix Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-19. The offering totals $3.0M, of which $150K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-08-19
- Form: D
- Accession: 0001496398-10-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $150K
- Remaining: $2.8M
- Investors: 3
- Date of first sale: 2010-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146692

## Issuer

- Name: Tonix Pharmaceuticals, Inc.
- CIK: 0001496398
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 9 WEST 57TH STREET, 26TH FLOOR, NEW YORK, NY, 10019
- Phone: 212-644-2610

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Stuart Davidson | Director | San Francisco, CA |
| Patrick Grace | Director | NEW YORK, NY |
| Donald Landry | Director | NEW YORK, NY |
| Seth Lederman | Director | New York, NY |
| Seth Lederman | Executive Officer | New York, NY |
| Seth Lederman | Promoter | New York, NY |

## More

- [CIK 1496398 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1496398&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001496398-10-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.